Mario Philips

Chief Executive Officer at

Polyneuros SAS

56 year

40 connections

Health Technology

Consumer Services

Electronic Technology

Profile

Mario Philips is currently the Chairman & Chief Executive Officer at Polyplus-transfection SA and the Chief Executive Officer at Polyneuros SAS. He is also the Chairman at Pll Therapeutics.
Previously, he held positions as the Chairman at Clean Biologics, Director at Artelis SA (Belgium), Director at Eurofins Disposable Lab SASU, Director at Austar Lifesciences Ltd., Independent Director at Orgenesis, Inc., Senior Vice President at ATMI, Inc., Vice President & General Manager at Danaher Corp., and General Manager at ATMI LifeSciences.
Mr. Philips received his undergraduate degree from Ghent University and his graduate degree from Groep T.

Mario Philips active positions

Companies	Position	Start
Polyneuros SAS	Chief Executive Officer	01/03/2019
Polyplus-transfection SA Polyplus-transfection SA BiotechnologyHealth Technology Provides cell and gene therapy services	Chief Executive Officer	01/11/2020
Pll Therapeutics	Chairman	-

All active positions of Mario Philips

Former positions of Mario Philips

Companies	Position	End
ORGENESIS INC.	Director/Board Member	27/06/2024
DANAHER CORPORATION	Corporate Officer/Principal	01/03/2019
AUSTAR LIFESCIENCES LIMITED	Director/Board Member	01/03/2019
Eurofins Disposable Lab SASU Eurofins Disposable Lab SASU Medical DistributorsDistribution Services Provides technology solutions for aseptic formulation and manufactures pharmaceutical products	Director/Board Member	01/03/2019
ATMI LifeSciences ATMI LifeSciences Medical SpecialtiesHealth Technology Develops and manufactures laboratory equipment, process materials and technology for semiconductor, display and life science industries	Corporate Officer/Principal	01/03/2014

See the detail of Mario Philips's experience

Training of Mario Philips

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mario Philips's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
ATMI, Inc. ATMI, Inc. SemiconductorsElectronic Technology Provides materials and materials packaging for manufacturing semiconductors and flat panel displays	Electronic Technology
Danaher Corp. Danaher Corp. Medical SpecialtiesHealth Technology Provides life sciences and diagnostic services	Health Technology
Orgenesis, Inc. Orgenesis, Inc. Packaged SoftwareTechnology Services Offers POCare services platform for biotech companies and hospitals to supply their products and develops potential of cell and gene therapies	Technology Services
Ghent University Ghent University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Polyplus-transfection SA Polyplus-transfection SA BiotechnologyHealth Technology Provides cell and gene therapy services	Health Technology
Groep T Groep T Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ATMI LifeSciences ATMI LifeSciences Medical SpecialtiesHealth Technology Develops and manufactures laboratory equipment, process materials and technology for semiconductor, display and life science industries	Health Technology
Artelis SA (Belgium) Artelis SA (Belgium) Environmental ServicesIndustrial Services Provides disposable bioprocess services	Industrial Services
Eurofins Disposable Lab SASU Eurofins Disposable Lab SASU Medical DistributorsDistribution Services Provides technology solutions for aseptic formulation and manufactures pharmaceutical products	Distribution Services
Austar Lifesciences Ltd. Austar Lifesciences Ltd. Industrial MachineryProducer Manufacturing Develops and manufactures fluid & biological process systems, clean room and automatic control and monitoring system	Producer Manufacturing
Polyneuros SAS
Clean Biologics Clean Biologics Pharmaceuticals: MajorHealth Technology Develops and manufactures virus based biopharmaceuticals	Health Technology
Pll Therapeutics